Johansson J S, Scharf D, Davies L A, Reddy K S, Eckenhoff R G
Department of Anesthesia, University of Pennsylvania, Philadelphia, PA 19104, USA.
Biophys J. 2000 Feb;78(2):982-93. doi: 10.1016/S0006-3495(00)76656-2.
The structural features of volatile anesthetic binding sites on proteins are being examined with the use of a defined model system consisting of a four-alpha-helix bundle scaffold with a hydrophobic core. Previous work has suggested that introducing a cavity into the hydrophobic core improves anesthetic binding affinity. The more polarizable methionine side chain was substituted for a leucine, in an attempt to enhance the dispersion forces between the ligand and the protein. The resulting bundle variant has an improved affinity (K(d) = 0.20 +/- 0.01 mM) for halothane binding, compared with the leucine-containing bundle (K(d) = 0.69 +/- 0.06 mM). Photoaffinity labeling with (14)C-halothane reveals preferential labeling of the W15 residue in both peptides, supporting the view that fluorescence quenching by bound anesthetic reports both the binding energetics and the location of the ligand in the hydrophobic core. The rates of amide hydrogen exchange were similar for the two bundles, suggesting that differences in binding affinity were not due to changes in protein stability. Binding of halothane to both four-alpha-helix bundle proteins stabilized the native folded conformations. Molecular dynamics simulations of the bundles illustrate the existence of the hydrophobic core, containing both W15 residues. These results suggest that in addition to packing defects, enhanced dispersion forces may be important in providing higher affinity anesthetic binding sites. Alternatively, the effect of the methionine substitution on halothane binding energetics may reflect either improved access to the binding site or allosteric optimization of the dimensions of the binding pocket. Finally, preferential stabilization of folded protein conformations may represent a fundamental mechanism of inhaled anesthetic action.
利用由具有疏水核心的四螺旋束支架组成的特定模型系统,正在研究蛋白质上挥发性麻醉剂结合位点的结构特征。先前的工作表明,在疏水核心中引入一个腔体会提高麻醉剂的结合亲和力。用更具极化性的甲硫氨酸侧链取代亮氨酸,试图增强配体与蛋白质之间的色散力。与含亮氨酸的束相比,所得的束变体对氟烷结合具有更高的亲和力(K(d)=0.20±0.01 mM),而含亮氨酸的束的K(d)=0.69±0.06 mM。用(14)C-氟烷进行光亲和标记显示,两种肽中W15残基都有优先标记,这支持了结合的麻醉剂引起的荧光猝灭反映了结合能和配体在疏水核心中位置的观点。两种束的酰胺氢交换速率相似,表明结合亲和力的差异不是由于蛋白质稳定性的变化。氟烷与两种四螺旋束蛋白的结合都稳定了天然折叠构象。束的分子动力学模拟说明了疏水核心的存在,其中包含两个W15残基。这些结果表明,除了堆积缺陷外,增强的色散力可能对提供更高亲和力的麻醉剂结合位点很重要。或者,甲硫氨酸取代对氟烷结合能的影响可能反映了进入结合位点的改善或结合口袋尺寸的变构优化。最后,折叠蛋白构象的优先稳定可能代表了吸入麻醉作用的基本机制。